Double Medical Technology Inc. (SHE:002901)
China · Delayed Price · Currency is CNY 40.53
-0.47 (-1.15%)
May 14, 2026, 3:04 PM CST
Double Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | 643.1 | 599.63 | 356.8 | 58.96 | 92.56 | 673.31 |
Depreciation & Amortization | 134.49 | 134.49 | 125.61 | 111.9 | 95.51 | 70.85 |
Other Amortization | 106.7 | 106.7 | 96.57 | 82.49 | 42 | 11.2 |
Loss (Gain) From Sale of Assets | -0.62 | -0.62 | -0.27 | -0.3 | 1.73 | 0 |
Asset Writedown & Restructuring Costs | 6.26 | 6.26 | 0.93 | 0.88 | 1.91 | 0.94 |
Loss (Gain) From Sale of Investments | -54.13 | -54.13 | -20.39 | -15.35 | -17.98 | -21.41 |
Provision & Write-off of Bad Debts | 1.19 | 1.19 | 6.02 | -1.13 | -2.07 | 16.24 |
Other Operating Activities | 72.32 | 71.34 | 64.83 | 57.46 | 4.52 | 18.43 |
Change in Accounts Receivable | -58.54 | -58.54 | 4.64 | 86.8 | 121.91 | -179.38 |
Change in Inventory | -109.47 | -109.47 | -220.53 | -422.18 | -418.26 | -140.44 |
Change in Accounts Payable | 88.78 | 88.78 | 26.68 | 118.18 | 103.13 | 189.28 |
Change in Other Net Operating Assets | 43.66 | 43.66 | 7.87 | - | 105.55 | 38.08 |
Operating Cash Flow | 875.77 | 831.34 | 442.3 | 73.89 | 128.44 | 673.26 |
Operating Cash Flow Growth | 110.74% | 87.96% | 498.58% | -42.47% | -80.92% | 21.14% |
Capital Expenditures | -144.66 | -133.51 | -270.46 | -305.72 | -285.07 | -235.11 |
Sale of Property, Plant & Equipment | 3.04 | 1.3 | 1.37 | 1.59 | 0.44 | 0.01 |
Cash Acquisitions | - | - | - | - | 1.66 | -88.02 |
Divestitures | -0.06 | -0.06 | - | - | - | - |
Investment in Securities | -573.26 | -543.27 | 406.86 | -213.77 | 40.75 | -96.03 |
Other Investing Activities | 39.89 | -2.66 | 13.75 | 9.89 | 16.74 | 22.59 |
Investing Cash Flow | -676.51 | -679.66 | 153.6 | -508.01 | -225.61 | -396.76 |
Long-Term Debt Issued | - | 94.87 | 159.05 | 532.61 | 50.77 | 1.11 |
Total Debt Issued | 140 | 94.87 | 159.05 | 532.61 | 50.77 | 1.11 |
Long-Term Debt Repaid | - | -178.15 | -377.83 | -12.33 | -11.36 | -8.33 |
Total Debt Repaid | -179.96 | -178.15 | -377.83 | -12.33 | -11.36 | -8.33 |
Net Debt Issued (Repaid) | -39.96 | -83.28 | -218.78 | 520.28 | 39.41 | -7.22 |
Issuance of Common Stock | 50.43 | 50.43 | - | - | 488.32 | 79.34 |
Repurchase of Common Stock | - | - | -234.98 | - | -75.68 | -2.92 |
Common Dividends Paid | -213.67 | -214.36 | -118.07 | -9.43 | -209.38 | -324.11 |
Other Financing Activities | -27.14 | -26.7 | -45.37 | -14.65 | 2.5 | -4.42 |
Financing Cash Flow | -230.35 | -273.91 | -617.2 | 496.2 | 245.16 | -259.33 |
Foreign Exchange Rate Adjustments | 1.02 | 5.71 | -11.37 | 1.06 | 4.31 | -3.55 |
Net Cash Flow | -30.07 | -116.52 | -32.68 | 63.14 | 152.3 | 13.61 |
Free Cash Flow | 731.11 | 697.83 | 171.84 | -231.82 | -156.63 | 438.15 |
Free Cash Flow Growth | 249.88% | 306.09% | - | - | - | 4.66% |
Free Cash Flow Margin | 27.16% | 26.83% | 8.05% | -15.12% | -10.92% | 21.97% |
Free Cash Flow Per Share | 1.80 | 1.71 | 0.41 | -0.55 | -0.37 | 1.09 |
Cash Income Tax Paid | 353.8 | 329.28 | 175.28 | 106.5 | 210.18 | 310.97 |
Levered Free Cash Flow | 574.97 | 539.67 | 72.26 | -105.63 | -240.44 | 303.33 |
Unlevered Free Cash Flow | 578.32 | 543.53 | 76.31 | -101.16 | -238.5 | 303.68 |
Change in Working Capital | -33.52 | -33.52 | -187.8 | -221.01 | -89.74 | -96.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.